DK233088D0 - Peptid med beskyttet c-terminal alfa-carboxylgruppe eller fysiologiske acceptable salte deraf, dets fremstilling og anvendelse som farmaceutikum - Google Patents

Peptid med beskyttet c-terminal alfa-carboxylgruppe eller fysiologiske acceptable salte deraf, dets fremstilling og anvendelse som farmaceutikum

Info

Publication number
DK233088D0
DK233088D0 DK233088A DK233088A DK233088D0 DK 233088 D0 DK233088 D0 DK 233088D0 DK 233088 A DK233088 A DK 233088A DK 233088 A DK233088 A DK 233088A DK 233088 D0 DK233088 D0 DK 233088D0
Authority
DK
Denmark
Prior art keywords
peptid
pharmaceutical
protected
manufacture
acceptable salts
Prior art date
Application number
DK233088A
Other languages
English (en)
Other versions
DK233088A (da
Inventor
Wolfgang Koenig
Peter Schindler
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK233088D0 publication Critical patent/DK233088D0/da
Publication of DK233088A publication Critical patent/DK233088A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK233088A 1987-04-29 1988-04-28 Peptid med beskyttet c-terminal alfa-carboxylgruppe eller fysiologiske acceptable salte deraf, dets fremstilling og anvendelse som farmaceutikum DK233088A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3714277 1987-04-29

Publications (2)

Publication Number Publication Date
DK233088D0 true DK233088D0 (da) 1988-04-28
DK233088A DK233088A (da) 1988-10-30

Family

ID=6326516

Family Applications (1)

Application Number Title Priority Date Filing Date
DK233088A DK233088A (da) 1987-04-29 1988-04-28 Peptid med beskyttet c-terminal alfa-carboxylgruppe eller fysiologiske acceptable salte deraf, dets fremstilling og anvendelse som farmaceutikum

Country Status (8)

Country Link
EP (1) EP0288965A2 (da)
JP (1) JPS63284197A (da)
KR (1) KR880012640A (da)
AU (1) AU1526388A (da)
DK (1) DK233088A (da)
IL (1) IL86195A0 (da)
PT (1) PT87350B (da)
ZA (1) ZA883033B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK15888D0 (da) * 1988-01-14 1988-01-14 Carlsberg Biotechnology Ltd Enzymatisk fremgangsmaade til fremstilling af immunmodulerende pentapeptider samt mellemprodukter til brug ved fremgangsmaaden
US5079260A (en) * 1989-06-22 1992-01-07 Nova Pharmaceutical Corporation Method for treating inflammation and compounds and compositions suitable for use therein
GB2239455B (en) * 1989-12-25 1993-12-15 Nisshin Flour Milling Co Formulations of lipolytic enzyme inhibitors and use of said inhibitors
US5376640A (en) * 1989-12-25 1994-12-27 Nisshin Flour Milling Co., Ltd. Lipolytic enzyme inhibitors
JP2960947B2 (ja) * 1989-12-25 1999-10-12 日清製粉株式会社 脂質分解酵素阻害剤
JPH07500814A (ja) * 1991-07-04 1995-01-26 ガーヴァン インスティチュート オブ メディカル リサーチ Ｐｌａ２阻害性化合物
US5466675A (en) * 1992-02-04 1995-11-14 Piljac; Goran Immunological activity of rhamnolipids
GB9206757D0 (en) * 1992-03-27 1992-05-13 Ferring Bv Novel peptide receptor ligands
GB9422294D0 (en) * 1994-11-04 1994-12-21 Peptide Therapeutics Ltd Peptides for anti-allergy treatment
CA2224062C (en) * 1995-06-06 2001-09-04 Pfizer Limited Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
KR100241643B1 (ko) 1995-06-06 2000-03-02 디. 제이. 우드 당뇨병치료제인 치환된 N-(인돌-2-카르보닐)-β-알라님아미드 및 그의 유도체
FI974437A7 (fi) 1995-06-06 1997-12-05 Pfizer Substituoituja N-(indoli-2-karbonyyli)amideja ja johdannaisia glykogee nifosforylaasi-inhibiittoreina
EP0920424B1 (en) 1996-08-22 2005-11-30 Warner-Lambert Company Llc Non-peptide bombesin receptor antagonists
US6737408B1 (en) 1997-08-07 2004-05-18 University Of Cincinnati Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
DE69936635T2 (de) * 1998-02-24 2008-05-08 Paradigm Biomedical, Inc., St. Petersburg Verwendundung von Rhamnolipiden als Kosmetika
AU2001270098A1 (en) * 2000-06-22 2002-01-02 San Diego State University Foundation Recombination modulators and methods for their production and use
US6277877B1 (en) 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
US20070197445A1 (en) 2006-01-18 2007-08-23 University Of Cincinnati Compounds for control of appetite

Also Published As

Publication number Publication date
ZA883033B (en) 1988-11-01
PT87350B (pt) 1992-08-31
EP0288965A2 (de) 1988-11-02
AU1526388A (en) 1988-11-03
KR880012640A (ko) 1988-11-28
PT87350A (pt) 1988-05-01
IL86195A0 (en) 1988-11-15
DK233088A (da) 1988-10-30
JPS63284197A (ja) 1988-11-21

Similar Documents

Publication Publication Date Title
DK233088D0 (da) Peptid med beskyttet c-terminal alfa-carboxylgruppe eller fysiologiske acceptable salte deraf, dets fremstilling og anvendelse som farmaceutikum
DK304488A (da) Borholdige peptider eller fysiologisk acceptable salte deraf og deres anvendelse samt mellemprodukter til dens fremstilling
NO873298L (no) Oralt terapeutisk system med systematisk virkning.
NO892834L (no) Imidoperoksikarboksylsyrer, dens fremstilling og anvendelse.
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
DK143588A (da) Substituerede 9-amino-tetrahydroacridiner, deres fremstilling og anvendelse som laegemidler
DK209188A (da) Bifunktionelle proteiner, deres fremstilling og anvendelse som laegemiddel
DK55088D0 (da) 3,4-dihydro-2h-benzo(b)pyraner, deres fremstilling og anvendelse som laegemidler
DK131887D0 (da) 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler
DK166214C (da) Gnrh-antagonistisk peptid og farmaceutisk acceptable salte heraf samt farmaceutisk praeparat indeholdende peptidet
DK366888D0 (da) Castanosperminestre og -glykosider, deres fremstilling og anvendelse som laegemidler
DK103987A (da) Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler
DK69389A (da) Renin-haemmende aminosyrederivater og fysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DE3886517D1 (de) Menschlicher Prourokinase ähnliches Polypeptid.
NO892744D0 (no) N-terminale aminodiol-aminosyrederivater og fremgangsmaatefor deres fremstilling.
DK144885D0 (da) Substituerede 4-hydroxybenzopyraner eller farmaceutisk acceptable additionssalte deraf, deres fremstilling og anvendelse som laegemidler
DK543788A (da) Reninhaemmende dipeptider eller fysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DK513188A (da) Aminosyreestre, deres fremstilling og anvendelse som laegemidler
DK47788A (da) 14,15-substituerede lanosteroler og fysiologisk acceptable salte deraf og deres anvendelse som farmaceutika
DK421389D0 (da) Aminomethyl-peptider, deres fremstilling og anvendelse som laegemidler
DK192588D0 (da) Pyrrolaldehyder eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK42888A (da) Arylthiadiazolylsulfonamider og derivater deraf, deres fremstilling og anvendelse som laegemiddel
DK238089A (da) Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK375689A (da) Isoxazolobenzoxazepiner, geometriske isomere, stereoisomere og farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK523289A (da) 2,3,5,6-tetrahydro(1,3,6)triazocino(1,2-a)benzim- idazoler eller farmaceutisk acceptable syreadditionssalte deraf og deres anvendelse

Legal Events

Date Code Title Description
ATS Application withdrawn